ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 791 filers reported holding ISHARES TR in Q3 2020. The put-call ratio across all filers is 1.64 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $728,227 | -8.1% | 5,307 | -9.0% | 0.00% | 0.0% |
Q4 2023 | $792,413 | -29.4% | 5,833 | -36.5% | 0.00% | 0.0% |
Q3 2023 | $1,123,112 | +14.9% | 9,184 | +19.3% | 0.00% | 0.0% |
Q2 2023 | $977,211 | +363.9% | 7,697 | +371.9% | 0.00% | – |
Q1 2023 | $210,660 | -92.1% | 1,631 | -92.0% | 0.00% | -100.0% |
Q4 2022 | $2,661,905 | -54.5% | 20,275 | -58.8% | 0.00% | -57.1% |
Q3 2022 | $5,853,000 | +38.9% | 49,241 | +38.8% | 0.01% | +75.0% |
Q2 2022 | $4,215,000 | +227.8% | 35,464 | +259.3% | 0.00% | +300.0% |
Q1 2022 | $1,286,000 | -92.0% | 9,869 | -90.6% | 0.00% | -87.5% |
Q4 2021 | $16,013,000 | +5.3% | 104,917 | +11.6% | 0.01% | 0.0% |
Q3 2021 | $15,205,000 | -56.9% | 94,035 | -56.4% | 0.01% | -57.9% |
Q2 2021 | $35,268,000 | +13.0% | 215,507 | +4.0% | 0.02% | +11.8% |
Q1 2021 | $31,205,000 | -6.1% | 207,261 | -5.5% | 0.02% | +6.2% |
Q4 2020 | $33,230,000 | -5.8% | 219,350 | -15.8% | 0.02% | -27.3% |
Q3 2020 | $35,261,000 | +14.2% | 260,409 | +15.3% | 0.02% | 0.0% |
Q2 2020 | $30,870,000 | +18.9% | 225,848 | -6.3% | 0.02% | 0.0% |
Q1 2020 | $25,971,000 | -42.3% | 241,059 | -35.5% | 0.02% | -33.3% |
Q4 2019 | $45,027,000 | +22.2% | 373,636 | +0.9% | 0.03% | +6.5% |
Q3 2019 | $36,860,000 | +54.4% | 370,470 | +69.3% | 0.03% | +47.6% |
Q2 2019 | $23,877,000 | +51.0% | 218,851 | +54.7% | 0.02% | +40.0% |
Q1 2019 | $15,813,000 | -20.0% | 141,438 | -31.0% | 0.02% | -28.6% |
Q4 2018 | $19,775,000 | -27.9% | 205,070 | -8.8% | 0.02% | -16.0% |
Q3 2018 | $27,410,000 | +1375.2% | 224,782 | +1228.8% | 0.02% | +1150.0% |
Q2 2018 | $1,858,000 | -30.9% | 16,916 | -32.8% | 0.00% | -33.3% |
Q1 2018 | $2,687,000 | +63.3% | 25,174 | +63.5% | 0.00% | +200.0% |
Q4 2017 | $1,645,000 | -89.2% | 15,399 | -66.4% | 0.00% | -93.3% |
Q3 2017 | $15,289,000 | -71.0% | 45,830 | -73.1% | 0.02% | -70.6% |
Q2 2017 | $52,763,000 | -62.9% | 170,158 | -64.9% | 0.05% | -60.2% |
Q1 2017 | $142,074,000 | +97.9% | 484,447 | +79.1% | 0.13% | +80.3% |
Q4 2016 | $71,784,000 | -25.6% | 270,495 | -18.8% | 0.07% | -22.0% |
Q3 2016 | $96,460,000 | +236.2% | 333,240 | +198.9% | 0.09% | +184.4% |
Q2 2016 | $28,693,000 | +428.3% | 111,500 | +435.4% | 0.03% | +357.1% |
Q1 2016 | $5,431,000 | -54.3% | 20,824 | -40.7% | 0.01% | -50.0% |
Q4 2015 | $11,875,000 | -96.5% | 35,098 | -96.9% | 0.01% | -96.6% |
Q3 2015 | $341,744,000 | +1084.2% | 1,126,640 | +1340.5% | 0.41% | +1364.3% |
Q2 2015 | $28,858,000 | -9.4% | 78,213 | -15.7% | 0.03% | -12.5% |
Q1 2015 | $31,847,000 | -77.8% | 92,733 | -80.4% | 0.03% | -75.0% |
Q4 2014 | $143,295,000 | +0.4% | 472,374 | -9.4% | 0.13% | +10.3% |
Q3 2014 | $142,697,000 | +26.9% | 521,495 | +19.2% | 0.12% | +26.1% |
Q2 2014 | $112,424,000 | +17.0% | 437,395 | +7.6% | 0.09% | -2.1% |
Q1 2014 | $96,068,000 | +761.7% | 406,379 | +727.6% | 0.09% | +840.0% |
Q4 2013 | $11,149,000 | +1122.5% | 49,102 | +1028.5% | 0.01% | +900.0% |
Q3 2013 | $912,000 | -98.1% | 4,351 | -98.4% | 0.00% | -97.9% |
Q2 2013 | $47,899,000 | -7.4% | 275,470 | -14.8% | 0.05% | -7.7% |
Q1 2013 | $51,729,000 | – | 323,442 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |